These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
870 related articles for article (PubMed ID: 22940758)
1. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A. Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758 [TBL] [Abstract][Full Text] [Related]
2. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide. Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245 [TBL] [Abstract][Full Text] [Related]
3. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells. Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639 [TBL] [Abstract][Full Text] [Related]
4. Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia. Cunha De Santis G; Tamarozzi MB; Sousa RB; Moreno SE; Secco D; Garcia AB; Lima AS; Faccioli LH; Falcão RP; Cunha FQ; Rego EM Haematologica; 2007 Dec; 92(12):1615-22. PubMed ID: 18055984 [TBL] [Abstract][Full Text] [Related]
5. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid. Imaizumi M; Sato A; Koizumi Y; Inoue S; Suzuki H; Suwabe N; Yoshinari M; Ichinohasama R; Endo K; Sawai T Leukemia; 1994 Aug; 8(8):1301-8. PubMed ID: 7520101 [TBL] [Abstract][Full Text] [Related]
6. Induction of differentiation of retinoic acid-resistant acute promyelocytic leukemia cells by the combination of all-trans retinoic acid and granulocyte colony-stimulating factor. Higuchi T; Kizaki M; Omine M Leuk Res; 2004 May; 28(5):525-32. PubMed ID: 15068906 [TBL] [Abstract][Full Text] [Related]
7. Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia. Matsui W; Smith BD; Vala M; Beal N; Huff CA; Diehl LF; Jones RJ Br J Haematol; 2005 Mar; 128(6):853-62. PubMed ID: 15755292 [TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide inhibits ATRA-induced prostaglandin E2 and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia. Habib A; Hamade E; Mahfouz R; Nasrallah MS; de Thé H; Bazarbachi A Leukemia; 2008 Jun; 22(6):1125-30. PubMed ID: 18354491 [TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells. Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552 [TBL] [Abstract][Full Text] [Related]
10. Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Ozpolat B; Akar U; Zorrilla-Calancha I; Vivas-Mejia P; Acevedo-Alvarez M; Lopez-Berestein G Apoptosis; 2008 Jul; 13(7):915-28. PubMed ID: 18491231 [TBL] [Abstract][Full Text] [Related]
11. Aquaporin 9, a promising predictor for the cytocidal effects of arsenic trioxide in acute promyelocytic leukemia cell lines and primary blasts. Iriyama N; Yuan B; Yoshino Y; Hatta Y; Horikoshi A; Aizawa S; Takeuchi J; Toyoda H Oncol Rep; 2013 Jun; 29(6):2362-8. PubMed ID: 23563754 [TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia: a paradigm for differentiation therapy. Grimwade D; Mistry AR; Solomon E; Guidez F Cancer Treat Res; 2010; 145():219-35. PubMed ID: 20306254 [TBL] [Abstract][Full Text] [Related]
13. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy. Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642 [TBL] [Abstract][Full Text] [Related]
14. Effect of cytokines on the proliferation and differentiation of acute promyelocytic leukemia cells: possible relationship to the development of "retinoic acid syndrome". Nakamaki T; Hino K; Yokoyama A; Hisatake J; Tomoyasu S; Honma Y; Hozumi M; Tsuruoka N Anticancer Res; 1994; 14(3A):817-23. PubMed ID: 7521152 [TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743 [TBL] [Abstract][Full Text] [Related]
16. Effects of colony-stimulating factors on the all-trans retinoic acid-induced differentiation of acute promyelocytic leukemic cells. Hsu HC; Tsai WH; Hsu ML; Ho CH; Wang SY Zhonghua Yi Xue Za Zhi (Taipei); 1996 Feb; 57(2):93-9. PubMed ID: 8634936 [TBL] [Abstract][Full Text] [Related]
17. Gefitinib enhances arsenic trioxide (AS2O3)-induced differentiation of acute promyelocytic leukemia cell line. Noh EK; Kim H; Park MJ; Baek JH; Park JH; Cha SJ; Won JH; Min YJ Leuk Res; 2010 Nov; 34(11):1501-5. PubMed ID: 20226526 [TBL] [Abstract][Full Text] [Related]
18. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Dubois C; Schlageter MH; de Gentile A; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y; Degos L Leukemia; 1994 Oct; 8(10):1750-7. PubMed ID: 7523800 [TBL] [Abstract][Full Text] [Related]